SG11202100767XA - Methods for treating neurodegenerative disorders - Google Patents
Methods for treating neurodegenerative disordersInfo
- Publication number
- SG11202100767XA SG11202100767XA SG11202100767XA SG11202100767XA SG11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- neurodegenerative disorders
- treating neurodegenerative
- treating
- disorders
- Prior art date
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713061P | 2018-08-01 | 2018-08-01 | |
| PCT/US2019/044023 WO2020028290A1 (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202100767XA true SG11202100767XA (en) | 2021-02-25 |
Family
ID=67614642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202100767XA SG11202100767XA (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12083082B2 (he) |
| EP (1) | EP3829563A1 (he) |
| JP (1) | JP7573512B2 (he) |
| KR (1) | KR102716959B1 (he) |
| CN (1) | CN112867485A (he) |
| AU (1) | AU2019315853A1 (he) |
| BR (1) | BR112021001739A2 (he) |
| CA (1) | CA3108150A1 (he) |
| CL (1) | CL2021000269A1 (he) |
| EA (1) | EA202190406A1 (he) |
| IL (1) | IL280424B1 (he) |
| MX (1) | MX2021001287A (he) |
| PH (1) | PH12021550213A1 (he) |
| SG (1) | SG11202100767XA (he) |
| WO (1) | WO2020028290A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4444286A1 (en) * | 2021-12-09 | 2024-10-16 | Alzheon, Inc. | Alz-801 for use in treating alzheimer's disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| ES2891278T3 (es) * | 2006-10-12 | 2022-01-26 | Bhi Lp | Métodos, compuestos, composiciones y vehículos para suministrar ácido 3-amino-1-propanosulfónico |
| WO2013177367A2 (en) | 2012-05-23 | 2013-11-28 | The Johns Hopkins University | Compounds and methods of use thereof for treating neurodegenerative disorders |
| WO2014121083A1 (en) * | 2013-01-31 | 2014-08-07 | President And Fellows Of Harvard College | Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition |
| FI3119911T3 (fi) * | 2014-03-21 | 2023-09-27 | Alzheon Inc | Yhdisteitä käytettäväksi alzheimerin taudin hoitamisessa apoe4+/+-potilaissa |
| MD3347002T2 (ro) * | 2015-09-10 | 2023-10-31 | Alzheon Inc | Tratamentul bolii Alzheimer într-o populație specifică de pacienți |
-
2019
- 2019-07-30 BR BR112021001739-9A patent/BR112021001739A2/pt unknown
- 2019-07-30 SG SG11202100767XA patent/SG11202100767XA/en unknown
- 2019-07-30 CA CA3108150A patent/CA3108150A1/en active Pending
- 2019-07-30 US US17/264,477 patent/US12083082B2/en active Active
- 2019-07-30 MX MX2021001287A patent/MX2021001287A/es unknown
- 2019-07-30 EA EA202190406A patent/EA202190406A1/ru unknown
- 2019-07-30 KR KR1020217005803A patent/KR102716959B1/ko active IP Right Grant
- 2019-07-30 WO PCT/US2019/044023 patent/WO2020028290A1/en unknown
- 2019-07-30 JP JP2021505721A patent/JP7573512B2/ja active Active
- 2019-07-30 CN CN201980064415.6A patent/CN112867485A/zh active Pending
- 2019-07-30 EP EP19752795.5A patent/EP3829563A1/en active Pending
- 2019-07-30 AU AU2019315853A patent/AU2019315853A1/en active Pending
- 2019-07-30 IL IL280424A patent/IL280424B1/he unknown
-
2021
- 2021-01-28 PH PH12021550213A patent/PH12021550213A1/en unknown
- 2021-02-01 CL CL2021000269A patent/CL2021000269A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102716959B1 (ko) | 2024-10-11 |
| IL280424A (he) | 2021-03-01 |
| US20210315847A1 (en) | 2021-10-14 |
| WO2020028290A1 (en) | 2020-02-06 |
| CN112867485A (zh) | 2021-05-28 |
| JP2021533128A (ja) | 2021-12-02 |
| KR20210039415A (ko) | 2021-04-09 |
| CA3108150A1 (en) | 2020-02-06 |
| IL280424B1 (he) | 2024-09-01 |
| JP7573512B2 (ja) | 2024-10-25 |
| CL2021000269A1 (es) | 2021-06-18 |
| EA202190406A1 (ru) | 2021-10-15 |
| PH12021550213A1 (en) | 2021-11-03 |
| AU2019315853A1 (en) | 2021-03-18 |
| US12083082B2 (en) | 2024-09-10 |
| BR112021001739A2 (pt) | 2021-04-27 |
| MX2021001287A (es) | 2021-07-15 |
| EP3829563A1 (en) | 2021-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267082A (he) | מערכות ושיטות לטיפול בהפרעות נוירולוגיות | |
| IL262222A (he) | נוגדנים נגד הזדקנות לטיפול בהפרעות של התנוונות העצב | |
| IL279308A (he) | שיטות לטיפול בהפרעות מתווכות–הפטידין | |
| IL273705B (he) | תרכובות בנזותיאזול ושיטות לשימוש בהן לטיפול במחלות נוירודגנרטיביות | |
| PT3119911T (pt) | Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+ | |
| SG10201913400QA (en) | Methods for treating lung disorders | |
| IL281052A (he) | טיפול בהפרעות בכבד | |
| EP3454885A4 (en) | PEPTIDES AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | |
| HK1256298A1 (zh) | 用於治療和預防神經退化性病症的組合物和方法 | |
| EP3902536A4 (en) | COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISORDERS | |
| EP3313387A4 (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| SG11202007286TA (en) | Methods for treating mitochondrial disorders | |
| IL286571A (he) | תרכובות ושיטות לטיפול בהפרעות נוירו -דגנרטיביות | |
| IL280441A (he) | תולדות של חומצה סולפופרופנואית לטיפול בהפרעות של התנוונות העצב | |
| GB201803010D0 (en) | Neurodegenerative disorders | |
| GB201701404D0 (en) | Therapies for treating inflammatory disorders | |
| IL289018A (he) | שיטות לטיפול באי סדרים של ניוון עצבי | |
| IL280424A (he) | שיטות לטיפול בהפרעות של התנוונות העצב | |
| EP3541474A4 (en) | TREATMENT OF BONE-RELATED DISORDERS | |
| GB201701455D0 (en) | Neurodegenerative disorders | |
| EP3962492A4 (en) | METHODS OF TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| EP3750592C0 (en) | MOVEMENT DISORDERS TREATMENT SYSTEM | |
| PT3420084T (pt) | Nova abordagem para tratamento de disfunções inflamatórias |